Concepedia

Sébastien Moréno

SM

Statistics

Publications

10

Citations

410

H-Index

10

Active since

2012

Affiliations

Institut de Pharmacologie Moléculaire et Cellulaire(Current)

Centre National de la Recherche Scientifique

Université Côte d'Azur

Inserm

Ludwig-Maximilians-Universität München

Sébastien Moréno is an author at Institut de Pharmacologie Moléculaire et Cellulaire specializing in neuroscience, life sciences, and molecular neuroscience.

ORCID

Publications per year

2012–2024

10

Publications

10

Ryanodine Receptor Blockade Reduces Amyloid-β Load and Memory Impairments in Tg2576 Mouse Model of Alzheimer Disease

Bénédicte Oulès, Dolores Del Prete, Barbara Greco et al. · Journal of Neuroscience · 2012 · 238 citations · Full text

, , +17

Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity

Alaeddine Djillani, Mariel Piétri, Sébastien Moréno et al. · Frontiers in Pharmacology · 2017 · 35 citations · Full text

, , +16

<i>In vitro</i>and<i>in vivo</i>regulation of synaptogenesis by the novel antidepressant spadin

Christelle Devader, Anouar Khayachi, J. Veyssière et al. · British Journal of Pharmacology · 2015 · 31 citations · Full text

, , +17

Potentiation of Calcium Influx and Insulin Secretion in Pancreatic Beta Cell by the Specific TREK-1 Blocker Spadin

Céline Hivelin, Sophie Béraud-Dufour, Christelle Devader et al. · Journal of Diabetes Research · 2016 · 20 citations · Full text

, , +17

Age‐dependent NMDA receptor function is regulated by the amyloid precursor protein

Joana Rajão‐Saraiva, Jade Dunot, Aurore Ribera et al. · Aging Cell · 2023 · 17 citations · Full text

, , +17

1–5 of 10